Hemodynamic Effects of Sacubitril-Valsartan in Heart Failure with Reduced-Ejection Fraction: Are All Doses Created Equal?

被引：0
|
作者：
Masetti, M. [1 ]
Corazza, F. [1 ]
Giovannini, L. [1 ]
Russo, A. [1 ]
Prestinenzi, P. [1 ]
Boschi, S. [1 ]
Potena, L. [1 ]
机构：
[1] Univ Bologna, Cardiovasc Dept, Bologna, Italy
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2020年 / 39卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
108
引用
收藏
页码：S53 / S53
页数：1
相关论文
共 50 条
  • [21] Sacubitril-valsartan modifies the indication of cardiac implantable devices in patients with heart failure and reduced ejection fraction
    Belarte-Tornero, Laia Carla
    Mojon, Diana
    Sole-Gonzalez, Eduard
    Ruiz-Bustillo, Sonia
    Valdivielso-More, Sandra
    Farre, Nuria
    REVISTA ESPANOLA DE CARDIOLOGIA, 2021, 74 (12): : 1118 - +
  • [22] Can Sacubitril-valsartan Improve Locomotor Muscle Microvascular Function In Heart Failure With Reduced Ejection Fraction?
    Bunsawat, Kanokwan
    Ratchford, Stephen M.
    Alpenglow, Jeremy K.
    Jarrett, Catherine L.
    Iacovelli, Jarred J.
    Park, Soung Hun
    Stehlik, Josef
    Smith, Adam S.
    Wray, D. Walter
    MEDICINE & SCIENCE IN SPORTS & EXERCISE, 2024, 56 (10) : 36 - 36
  • [23] Commentary to Impact of Sacubitril-Valsartan Treatment on Diastolic Function in Patients with Heart Failure and Reduced Ejection Fraction
    Buonacera, Agata
    Stancanelli, Benedetta
    Malatino, Lorenzo
    HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2021, 28 (04) : 331 - 332
  • [24] EFFECTS OF SACUBITRIL-VALSARTAN IN HEART FAILURE WITH PRESERVED EJECTION FRACTION IN PATIENTS UNDERGOING PERITONEAL DIALYSIS
    Fu, Sha
    Xu, Zhenjian
    Lin, Baojuan
    Chen, Junzhe
    Huang, Qiuyan
    Xu, Yanchun
    Xu, Anping
    Chen, Yangxin
    Tang, Ying
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1558 - 1558
  • [25] Effects of Sacubitril-Valsartan in Heart Failure With Preserved Ejection Fraction in Patients Undergoing Peritoneal Dialysis
    Fu, Sha
    Xu, Zhenjian
    Lin, Baojuan
    Chen, Junzhe
    Huang, Qiuyan
    Xu, Yanchun
    Xu, Anping
    Chen, Yangxin
    Tang, Ying
    FRONTIERS IN MEDICINE, 2021, 8
  • [26] Commentary to Impact of Sacubitril-Valsartan Treatment on Diastolic Function in Patients with Heart Failure and Reduced Ejection Fraction
    Agata Buonacera
    Benedetta Stancanelli
    Lorenzo Malatino
    High Blood Pressure & Cardiovascular Prevention, 2021, 28 : 331 - 332
  • [27] Sacubitril-valsartan treatment is associated with decrease in central apneas in patients with heart failure with reduced ejection fraction
    Passino, Claudio
    Sciarrone, Paolo
    Vergaro, Giuseppe
    Borrelli, Chiara
    Spiesshoefer, Jens
    Gentile, Francesco
    Emdin, Michele
    Giannoni, Alberto
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 330 : 112 - 119
  • [28] Cost-Effectiveness of Sacubitril-Valsartan in Patients Who Have Heart Failure With Reduced Ejection Fraction
    King, Jordan
    Bress, Adam
    Bellows, Brandon
    ANNALS OF INTERNAL MEDICINE, 2017, 166 (08) : 606 - 607
  • [29] Echocardiographic changes in elderly patients with heart failure with reduced ejection fraction after sacubitril-valsartan treatment
    Gu, Wei
    Xu, Chuangye
    Li, Zhao
    Li, Zhi-Zhong
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2021, 11 (05) : 1093 - 1100
  • [30] Comparative Cost-Effectiveness of Sacubitril-Valsartan, Dapagliflozin, and Empagliflozin in Heart Failure With Reduced Ejection Fraction
    Parikh, Neil U.
    Dixit, Neal
    Ziaeian, Boback
    Fonarow, Gregg C.
    CIRCULATION, 2022, 146
12345